Drug Trial Radar · NCT04869579
Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients.
Last checked: Nov 20, 2026Latest source record: Aug 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
100
Planned (sponsor's estimate)
Start
Aug 15, 2021
Primary completion
Nov 15, 2021
Study completion Dec 15, 2021
Sponsor
- Lead sponsor
- CHRISTUS HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Pharco Pharmaceuticals
- First posted
- May 3, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Given its anti-viral, anti-oxidative, immune-enhancing, cytokine-modulating, and anticoagulant properties, the investigators hypothesize that Selenium infusion at supranutritional doses for moderately-ill, severely-ill, and critically-ill COVID-19 patients will prevent further clinical deterioration thus decreasing overall mortality and improving survival. To test this hypothesis, a prospective, single-center, phase II trial is proposed to assess the efficacy of Selenium in hospitalized adult patients with moderate, severe, and critical COVID-19 infections.
Conditions
- Covid19
Interventions
Selenium (as Selenious Acid)Drug
Interventional arm participants will receive Selenium as Selenious Acid infusion plus the standard of care therapy.
PlaceboOther
Active comparator arm participants will receive the standard of care therapy plus a Saline-based placebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean change in the ordinal scaleTime frame: Day 1 through Day 29
- Rate of hospital discharges or deathsTime frame: Study duration
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CHRISTUS Good Shepherd Medical Center
Longview, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.